GALACTIC HF (Completed)
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction
- Medicine
- omecamtiv mecarbil
- Population
- Heart failure
- Phase
- III
- Starting year
- 2016
- More information
- ClinicalTrials.gov